Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

Antiangiogenic activity of indole-3-carbinol in endothelial cells stimulated with activated macrophages.

Wang ML, Shih CK, Chang HP, Chen YH.

Food Chem. 2012 Sep 15;134(2):811-20. doi: 10.1016/j.foodchem.2012.02.185. Epub 2012 Mar 7.

PMID:
23107695
3.

(+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.

Guruvayoorappan C, Kuttan G.

Innate Immun. 2008 Jun;14(3):160-74. doi: 10.1177/1753425908093295.

PMID:
18562575
4.
5.

Suppression of inflammation-associated factors by indole-3-carbinol in mice fed high-fat diets and in isolated, co-cultured macrophages and adipocytes.

Chang HP, Wang ML, Hsu CY, Liu ME, Chan MH, Chen YH.

Int J Obes (Lond). 2011 Dec;35(12):1530-8. doi: 10.1038/ijo.2011.12. Epub 2011 Feb 22. Erratum in: Int J Obes (Lond). 2013 Feb;37(2):324.

7.

Antiangiogenic effects of indole-3-carbinol and 3,3'-diindolylmethane are associated with their differential regulation of ERK1/2 and Akt in tube-forming HUVEC.

Kunimasa K, Kobayashi T, Kaji K, Ohta T.

J Nutr. 2010 Jan;140(1):1-6. doi: 10.3945/jn.109.112359. Epub 2009 Nov 4.

PMID:
19889811
8.

Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.

Hamsa TP, Kuttan G.

Immunopharmacol Immunotoxicol. 2011 Sep;33(3):488-97. doi: 10.3109/08923973.2010.531277. Epub 2010 Nov 9.

PMID:
21058930
9.

In vitro suppression of growth of murine WEHI-3 leukemia cells and in vivo promotion of phagocytosis in a leukemia mice model by indole-3-carbinol.

Lu HF, Tung WL, Yang JS, Huang FM, Lee CS, Huang YP, Liao WY, Chen YL, Chung JG.

J Agric Food Chem. 2012 Aug 8;60(31):7634-43. doi: 10.1021/jf300963t. Epub 2012 Jul 26.

PMID:
22775144
10.

Indole-3-carbinol (I3C) exhibits inhibitory and preventive effects on prostate tumors in mice.

Souli E, Machluf M, Morgenstern A, Sabo E, Yannai S.

Food Chem Toxicol. 2008 Mar;46(3):863-70. Epub 2007 Oct 30.

PMID:
18063461
11.

Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.

Pratheeshkumar P, Kuttan G.

Eur J Pharmacol. 2011 Apr 10;656(1-3):10-8. doi: 10.1016/j.ejphar.2010.12.041. Epub 2011 Jan 20.

PMID:
21256125
13.

Antiangiogenic properties of 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin: an orally bioavailable heat shock protein 90 modulator.

Kaur G, Belotti D, Burger AM, Fisher-Nielson K, Borsotti P, Riccardi E, Thillainathan J, Hollingshead M, Sausville EA, Giavazzi R.

Clin Cancer Res. 2004 Jul 15;10(14):4813-21.

16.

Antiangiogenic activity of Diallyl Sulfide (DAS).

Thejass P, Kuttan G.

Int Immunopharmacol. 2007 Mar;7(3):295-305. Epub 2006 Nov 28.

PMID:
17276887
17.

Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.

Hamsa TP, Kuttan G.

Eur J Pharmacol. 2010 Dec 15;649(1-3):64-73. doi: 10.1016/j.ejphar.2010.09.010. Epub 2010 Sep 19.

PMID:
20858484
18.

SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.

Cao ZX, Zheng RL, Lin HJ, Luo SD, Zhou Y, Xu YZ, Zeng XX, Wang Z, Zhou LN, Mao YQ, Yang L, Wei YQ, Yu LT, Yang SY, Zhao YL.

Cell Physiol Biochem. 2011;27(5):565-74. doi: 10.1159/000329978. Epub 2011 Jun 15.

19.

Fisetin inhibits various attributes of angiogenesis in vitro and in vivo--implications for angioprevention.

Bhat TA, Nambiar D, Pal A, Agarwal R, Singh RP.

Carcinogenesis. 2012 Feb;33(2):385-93. doi: 10.1093/carcin/bgr282. Epub 2011 Dec 1.

PMID:
22139440
20.

Influence of VEGF stimulated human macrophages on the proliferation of dermal microvascular endothelial cells: Coculture experiments.

Hiebl B, Bog S, Mrowietz C, J√ľnger M, Jung F, Lendlein A, Franke RP.

Clin Hemorheol Microcirc. 2010;46(2-3):211-6. doi: 10.3233/CH-2010-1347.

PMID:
21135496

Supplemental Content

Support Center